UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060966
Receipt number R000069716
Scientific Title The Nationwide Registration Initiative for Lung Malignancy in Japan
Date of disclosure of the study information 2026/03/31
Last modified on 2026/03/17 17:51:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Nationwide Registration Initiative for Lung Malignancy in Japan

Acronym

Trinity study

Scientific Title

The Nationwide Registration Initiative for Lung Malignancy in Japan

Scientific Title:Acronym

Trinity study

Region

Japan


Condition

Condition

Small Cell Lung Cancer

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate real-world reatment patterns and clinical outcomes of patients with small cell lung cancer in Japan

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Overall Survival

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1, Pathologically diagnosed as small cell lung cancer after 27th March 2025
2, 18 years or older at time of diagnosed as small cell lung cancer
3, Provided written informed consent

Key exclusion criteria

None

Target sample size

775


Research contact person

Name of lead principal investigator

1st name Hirotsugu
Middle name
Last name Kenmotsu

Organization

Shizuoka Cancer Center

Division name

Division of Thoracic Oncology

Zip code

411-8777

Address

1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka Prefecture

TEL

055-989-5222

Email

h.kenmotsu@scchr.jp


Public contact

Name of contact person

1st name Hirotsgu
Middle name
Last name Kenmotsu

Organization

Shizuoka Cancer Center

Division name

Division of Thoracic Oncology

Zip code

4118777

Address

1007 Shimonagakubo, Nagaizumi-cho, Suntou-gun, Shizuoka

TEL

055-989-5222

Homepage URL


Email

h.kenmotsu@scchr.jp


Sponsor or person

Institute

Shizuoka Cancer Center

Institute

Department

Personal name



Funding Source

Organization

Other

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shizuoka Cancer Center Research Ethics Review Committee

Address

1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka Prefecture

Tel

0559895222

Email

rinsho_office@scchr.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 09 Month 14 Day

Date of IRB

2026 Year 01 Month 08 Day

Anticipated trial start date

2026 Year 03 Month 01 Day

Last follow-up date

2031 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational Study


Management information

Registered date

2026 Year 03 Month 17 Day

Last modified on

2026 Year 03 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069716